But clinical trials may offer hope. Hope for potentially life-changing medicines — here's how. Over the past two decades, the U.S. Food and Drug Administration (FDA) has approved more than 900 new ...

Fate Therapeutics, Inc. FATE presented encouraging initial clinical and translational data from the first patient treated in ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

Dr. Amaka Eneanya reflects on lessons learned in the first year of her new position and the importance of keeping health ...

A previous pilot study examining the company’s SJP-001 compound found it was able to cut hangover symptoms such as headaches, ...

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

The MoU integrates NABH’s expertise in national accreditation programs with RSSDI’s clinical insights to develop specialized ...

This product is intended to promote estrogen but does not contain estrogen. About Life Extension® For more than 40 years, Life Extension has pursued innovative advances in health, conducting rigorous ...

THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in ...

ANKET ® ( A ntibody-based NK cell E ngager T herapeutics) is Innate's proprietary platform for developing next-generation, multi-specific natural killer (NK) cell engagers to treat certain types of ...